Skip to content

A Randomized Study Evaluating the Role of Ultra-sound Guidance When Drawing Radial Arterial Blood Samples

A Randomized Study Evaluating the Role of Ultra-sound Guidance When Drawing Radial Arterial Blood Samples

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01789801
Acronym
ECHO-PARDIF
Enrollment
74
Registered
2013-02-12
Start date
2014-02-21
Completion date
2016-06-08
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radial Artery, Ultrasonography

Brief summary

Previous studies have demonstrated that an experienced ultrasound operator is able to efficiently perform radial arterial puncture on patients where an initial operator failed to puncture arteries via simple palpation. The objective of this study is to compare difficult-to-puncture patients randomized into two groups: one group where ultrasound is used to aid artery localisation, and one group where only palpation is used.

Detailed description

test

Interventions

PROCEDURERAP palpation only

Skin disinfection by local antiseptic. Identification of the radial artery by palpation. Insertion of the needle positioned at 70 ° with regard to the artery palpated. Check the rise of arterial blood in the syringe.

PROCEDURERAP with ultrasound guidance

Skin disinfection by local antiseptic. Application of sterile gel. Identification of the artery via ultrasound vascular probe. Center the artery at the center of the screen. Introduction of the syringe at 70 ° with respect to the probe, in center of visualized zone. Check the rise of arterial blood in the syringe.

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient's health status necessitates an arterial blood sample AND his/her radial arteries are deemed unpalpable OR two previous attempts at radial arterial puncture by a nurse resulted in failure

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, or any kind of guardianship * The patient refuses to sign the consent * It is impossible to correctly inform the patient * The patient is pregnant, parturient, or breastfeeding * Arterial puncture is required on femoral, humeral or axillary arteries * The patient is in cardiac arrest * The patient has known circulatory problems, ischemia, local infection * The patient has a severe bleeding or hemostasis disorder (hemophilia, hypoprothrombinemia, platelets \<50,000) * The patient is an upper limb amputee, or his/her arm is in a cast * The patient has known allergies to methyl or propylbenzoate, propylene glycol or chlorexhidine gluconate

Design outcomes

Primary

MeasureTime frame
Only one attempt at arterial puncture was necessary (yes/no)Day 0 - end of procedure

Secondary

MeasureTime frameDescription
Length of time necessary for the procedureDay 0 - end of procedure
Presence/absence of complicationsDay 0 - end of procedurePresence/absence of complications including hematoma, nerve injury, vagal reaction, pseudo-aneurysm.
Patient satisfactionDay 0 - end of procedurePatient satisfaction is evaluated using a visual analog scale.
Number of skin puncturesDay 0 - end of procedure
Patient pain evaluationDay 0 - end of procedurePatients are asked to evaluate the experienced pain level using a visual analog scale.
The number of catheters usedDay 0 - end of procedure
Was additional assistance necessary? yes/noDay 0 - end of procedure
Operator satisfactionDay 0 - end of procedureOperator satisfaction is estimated using a visual analog scale.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026